Physician profile
Selorm Takyi
NPI 1316334998
$1,171.89
in general payments reported to CMS, 2019-2025
19 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $288 · 2021: $38.54 · 2022: $148 · 2023: $162 · 2024: $301 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $169.51 | 2019-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $166.71 | 2019-2025 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $166.43 | 2020-2025 | |
| Nalu Medical, INC. | $135.48 | 2024 | Nalu Neurostimulation System |
| Arbor Pharmaceuticals, INC. | $99.66 | 2019-2020 | |
| Protega Pharmaceutials INC | $98.72 | 2023-2024 | Roxybond |
| Bioventus LLC | $78.04 | 2022-2025 | Gelsyn-3, Durolane |
| Sonex Health, INC. | $41.91 | 2020 | |
| Avanos Medical | $32.80 | 2023-2024 | Trays- All, Trivisc Sodium Hyaluronate |
| Kowa Pharmaceuticals America, INC. | $30.67 | 2022-2023 | Seglentis |
| Si-Bone, INC. | $28.06 | 2024 | |
| Pfizer INC. | $26.37 | 2019-2020 | |
| Forte Bio-Pharma LLC | $17.08 | 2025 | Prolate, Nalocet, Tanlor |
| Sanofi-Aventis U.S. LLC | $15.31 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $15.21 | 2023 | Zilretta, Iovera, Exparel |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.64 | 2020 | |
| Abbott Laboratories | $13.49 | 2022 | |
| Depuy Synthes Sales INC. | $13.42 | 2023 | Monovisc, Orthovisc |
| Foundation Fusion Solutions, LLC | $9.38 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Selorm Takyi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.